Avatrombopag vs. Placebo for CIT in GI Malignancies

NCT05772546 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Gastrointestinal Cancer
Gastrointestinal Neoplasms
Chemotherapy-Induced Thrombocytopenia

Interventions

DRUG: Avatrombopag
DRUG: Matching Placebo

Sponsor

Hanny Al-Samkari, MD

Collaborators

[object Object]